{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:45:17Z","timestamp":1792395917173,"version":"4.4.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1704177"],"award-info":[{"award-number":["U1704177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1704177"],"award-info":[{"award-number":["U1704177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1704177"],"award-info":[{"award-number":["U1704177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1704177"],"award-info":[{"award-number":["U1704177"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["81871811"],"award-info":[{"award-number":["81871811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["81871811"],"award-info":[{"award-number":["81871811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["81871811"],"award-info":[{"award-number":["81871811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["81871811"],"award-info":[{"award-number":["81871811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rheumatoid arthritis (RA) is a common autoimmune rheumatic disease that causes chronic synovitis, bone erosion, and joint destruction. The autoantigens in RA include a wide array of posttranslational modified proteins, such as citrullinated proteins catalyzed by peptidyl arginine deiminase4a. Pathogenic anti-citrullinated protein antibodies (ACPAs) directed against a variety of citrullinated epitopes are abundant both in plasma and synovial fluid of RA patients. ACPAs play an important role in the onset and progression of RA. Intensive and extensive studies are being conducted to unveil the mechanisms of RA pathogenesis and evaluate the efficacy of some investigative drugs. In this review, we focus on the formation and pathogenic function of ACPAs.<\/jats:p>","DOI":"10.1007\/s10238-024-01359-3","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T02:01:46Z","timestamp":1720404106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The role of anti-citrullinated protein antibody in pathogenesis of RA"],"prefix":"10.1007","volume":"24","author":[{"given":"Hang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3039-8676","authenticated-orcid":false,"given":"Tian-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"issue":"9746","key":"1359_CR1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"D Scott","year":"2010","unstructured":"Scott D, Wolfe F, Huizinga T. Rheumatoid arthritis. Lancet (London, England). 2010;376(9746):1094\u2013108.","journal-title":"Lancet (London, England)"},{"issue":"4","key":"1359_CR2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00281-017-0627-z","volume":"39","author":"V Derksen","year":"2017","unstructured":"Derksen V, Huizinga TWJ, van der Woude D. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin Immunopathol. 2017;39(4):437\u201346.","journal-title":"Semin Immunopathol"},{"issue":"5","key":"1359_CR3","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102506","volume":"19","author":"M Mahler","year":"2020","unstructured":"Mahler M, Martinez-Prat L, Sparks JA, Deane KD. Precision medicine in the care of rheumatoid arthritis: focus on prediction and prevention of future clinically-apparent disease. Autoimmun Rev. 2020;19(5): 102506.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1359_CR4","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","volume":"79","author":"E Myasoedova","year":"2020","unstructured":"Myasoedova E, Davis J, Matteson EL, Crowson CS. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985\u20132014. Ann Rheum Dis. 2020;79(4):440\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1359_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.41417","volume":"73","author":"KD Deane","year":"2021","unstructured":"Deane KD, Holers VM. Rheumatoid arthritis pathogenesis, prediction, and prevention: an emerging paradigm shift. Arthritis Rheumatol. 2021;73(2):181\u201393.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"1359_CR6","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/annrheumdis-2017-211325","volume":"76","author":"LE Burgers","year":"2017","unstructured":"Burgers LE, van Steenbergen HW, Ten Brinck RM, Huizinga TW, van der Helm-van Mil AH. Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis. Ann Rheum Dis. 2017;76(10):1751\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1359_CR7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/14728222.2017.1294160","volume":"21","author":"S Koushik","year":"2017","unstructured":"Koushik S, Joshi N, Nagaraju S, Mahmood S, Mudeenahally K, Padmavathy R, et al. PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis. Expert Opin Ther Targets. 2017;21(4):433\u201347.","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"1359_CR8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","volume":"63","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, Radstake TR, van der Heijden A, van Mansum MA, Dieteren C, de Rooij DJ, et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis. 2004;63(4):373\u201381.","journal-title":"Ann Rheum Dis"},{"key":"1359_CR9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2017.01.006","volume":"80","author":"M Bawadekar","year":"2017","unstructured":"Bawadekar M, Shim D, Johnson CJ, Warner TF, Rebernick R, Damgaard D, et al. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation. J Autoimmun. 2017;80:39\u201347.","journal-title":"J Autoimmun"},{"key":"1359_CR10","doi-asserted-by":"crossref","first-page":"26430","DOI":"10.1038\/srep26430","volume":"6","author":"J Kawalkowska","year":"2016","unstructured":"Kawalkowska J, Quirke AM, Ghari F, Davis S, Subramanian V, Thompson PR, et al. Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses. Sci Rep. 2016;6:26430.","journal-title":"Sci Rep"},{"issue":"9","key":"1359_CR11","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.3390\/cimb44090293","volume":"44","author":"MG Matuz-Flores","year":"2022","unstructured":"Matuz-Flores MG, Rosas-Rodriguez JA, Tortoledo-Ortiz O, Munoz-Barrios S, Martinez-Bonilla GE, Hernandez-Bello J, et al. PADI4 haplotypes contribute to mRNA expression, the enzymatic activity of peptidyl arginine deaminase and rheumatoid arthritis risk in patients from Western Mexico. Curr Issues Mol Biol. 2022;44(9):4268\u201381.","journal-title":"Curr Issues Mol Biol"},{"issue":"7490","key":"1359_CR12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature12942","volume":"507","author":"MA Christophorou","year":"2014","unstructured":"Christophorou MA, Castelo-Branco G, Halley-Stott RP, Oliveira CS, Loos R, Radzisheuskaya A, et al. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature. 2014;507(7490):104\u20138.","journal-title":"Nature"},{"issue":"2","key":"1359_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41584-019-0352-1","volume":"16","author":"G Wigerblad","year":"2020","unstructured":"Wigerblad G, Kaplan MJ. NETs spread ever wider in rheumatic diseases. Nat Rev Rheumatol. 2020;16(2):73\u20134.","journal-title":"Nat Rev Rheumatol"},{"issue":"22","key":"1359_CR14","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1021\/bi700095s","volume":"46","author":"B Knuckley","year":"2007","unstructured":"Knuckley B, Bhatia M, Thompson P. Protein arginine deiminase 4: evidence for a reverse protonation mechanism. Biochemistry. 2007;46(22):6578\u201387.","journal-title":"Biochemistry"},{"issue":"7","key":"1359_CR15","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/jth.15313","volume":"19","author":"X Liu","year":"2021","unstructured":"Liu X, Arfman T, Wichapong K, Reutelingsperger CPM, Voorberg J, Nicolaes GAF. PAD4 takes charge during neutrophil activation: Impact of PAD4 mediated NET formation on immune-mediated disease. J Thromb Haemost. 2021;19(7):1607\u201317.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"1359_CR16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/annrheumdis-2019-216499","volume":"79","author":"T Kissel","year":"2020","unstructured":"Kissel T, Reijm S, Slot LM, Cavallari M, Wortel CM, Vergroesen RD, et al. Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications. Ann Rheum Dis. 2020;79(4):472\u201380.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1359_CR17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13075-018-1540-0","volume":"20","author":"C Schwedler","year":"2018","unstructured":"Schwedler C, Haupl T, Kalus U, Blanchard V, Burmester GR, Poddubnyy D, et al. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity. Arthritis Res Ther. 2018;20(1):44.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"1359_CR18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/annrheumdis-2021-221754","volume":"81","author":"S Saevarsdottir","year":"2022","unstructured":"Saevarsdottir S, Stefansdottir L, Sulem P, Thorleifsson G, Ferkingstad E, Rutsdottir G, et al. Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset. Ann Rheum Dis. 2022;81(8):1085\u201395.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1359_CR19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/14728222.2018.1526924","volume":"22","author":"FD Carmona","year":"2018","unstructured":"Carmona FD, Martin J. The potential of PTPN22 as a therapeutic target for rheumatoid arthritis. Expert Opin Ther Targets. 2018;22(10):879\u201391.","journal-title":"Expert Opin Ther Targets"},{"key":"1359_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","volume":"31","author":"KD Deane","year":"2017","unstructured":"Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2017;31:3\u201318.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1359_CR21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gene.2019.03.033","volume":"702","author":"J Karami","year":"2019","unstructured":"Karami J, Aslani S, Jamshidi A, Garshasbi M, Mahmoudi M. Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review. Gene. 2019;702:8\u201316.","journal-title":"Gene"},{"issue":"4","key":"1359_CR22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00281-017-0624-2","volume":"39","author":"D Alpizar-Rodriguez","year":"2017","unstructured":"Alpizar-Rodriguez D, Finckh A. Environmental factors and hormones in the development of rheumatoid arthritis. Semin Immunopathol. 2017;39(4):461\u20138.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"1359_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","volume":"31","author":"KD Deane","year":"2017","unstructured":"Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2017;31(1):3\u201318.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"1359_CR24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4081\/reumatismo.2016.892","volume":"68","author":"G Cafaro","year":"2016","unstructured":"Cafaro G, Alunno A, Valentini V, Leone MC, Marcucci E, Bartoloni E, et al. The onset site of rheumatoid arthritis: the joints or the lung? Reumatismo. 2016;68(4):167\u201375.","journal-title":"Reumatismo"},{"issue":"2","key":"1359_CR25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.41091","volume":"72","author":"LB Kelmenson","year":"2020","unstructured":"Kelmenson LB, Wagner BD, McNair BK, Frazer-Abel A, Demoruelle MK, Bergstedt DT, et al. Timing of elevations of autoantibody isotypes prior to diagnosis of rheumatoid arthritis. Arthrit Rheumatol (Hoboken, NJ). 2020;72(2):251\u201361.","journal-title":"Arthrit Rheumatol (Hoboken, NJ)"},{"issue":"9","key":"1359_CR26","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/jcm8091309","volume":"8","author":"E G\u00f3mez-Ba\u00f1uelos","year":"2019","unstructured":"G\u00f3mez-Ba\u00f1uelos E, Mukherjee A, Darrah E, Andrade F. Rheumatoid arthritis-associated mechanisms of porphyromonas gingivalis and aggregatibacter actinomycetemcomitans. J Clin Med. 2019;8(9):1309.","journal-title":"J Clin Med"},{"issue":"5","key":"1359_CR27","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/rheumatology\/kez368","volume":"59","author":"X Mariette","year":"2020","unstructured":"Mariette X, Perrodeau E, Verner C, Struillou X, Picard N, Schaeverbeke T, et al. Role of good oral hygiene on clinical evolution of rheumatoid arthritis: a randomized study nested in the ESPOIR cohort. Rheumatology. 2020;59(5):988\u201396.","journal-title":"Rheumatology"},{"issue":"6","key":"1359_CR28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41584-020-0409-1","volume":"16","author":"AM Curran","year":"2020","unstructured":"Curran AM, Naik P, Giles JT, Darrah E. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets. Nat Rev Rheumatol. 2020;16(6):301\u201315.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"1359_CR29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/imr.12834","volume":"294","author":"J Fert-Bober","year":"2020","unstructured":"Fert-Bober J, Darrah E, Andrade F. Insights into the study and origin of the citrullinome in rheumatoid arthritis. Immunol Rev. 2020;294(1):133\u201347.","journal-title":"Immunol Rev"},{"key":"1359_CR30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.840035","volume":"13","author":"MF Hemon","year":"2022","unstructured":"Hemon MF, Lambert NC, Arnoux F, Roudier J, Auger I. PAD4 immunization triggers anti-citrullinated peptide antibodies in normal mice: analysis with peptide arrays. Front Immunol. 2022;13: 840035.","journal-title":"Front Immunol"},{"key":"1359_CR31","volume":"11","author":"W Song","year":"2020","unstructured":"Song W, Ye J, Pan N, Tan C, Herrmann M. Neutrophil extracellular traps tied to rheumatoid arthritis: points to ponder. Front Immunol. 2020;11: 578129.","journal-title":"Front Immunol"},{"key":"1359_CR32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102542","volume":"116","author":"N Balandraud","year":"2021","unstructured":"Balandraud N, Auger I, Roudier J. Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins? J Autoimmun. 2021;116: 102542.","journal-title":"J Autoimmun"},{"issue":"9","key":"1359_CR33","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20100239","volume":"207","author":"P Li","year":"2010","unstructured":"Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207(9):1853\u201362.","journal-title":"J Exp Med"},{"key":"1359_CR34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","volume":"26","author":"L Klareskog","year":"2008","unstructured":"Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol. 2008;26:651\u201375.","journal-title":"Annu Rev Immunol"},{"key":"1359_CR35","doi-asserted-by":"crossref","first-page":"1077041","DOI":"10.3389\/fimmu.2023.1077041","volume":"14","author":"Y Song","year":"2023","unstructured":"Song Y, Wang Z, Kang L, He Z, Zhao S, Fang X, et al. PADs and NETs in digestive system: from physiology to pathology. Front Immunol. 2023;14:1077041.","journal-title":"Front Immunol"},{"issue":"4","key":"1359_CR36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/imm.13412","volume":"164","author":"U Karmakar","year":"2021","unstructured":"Karmakar U, Vermeren S. Crosstalk between B cells and neutrophils in rheumatoid arthritis. Immunology. 2021;164(4):689\u2013700.","journal-title":"Immunology"},{"issue":"5","key":"1359_CR37","first-page":"616","volume":"12","author":"JE Jones","year":"2009","unstructured":"Jones JE, Causey CP, Knuckley B, Slack-Noyes JL, Thompson PR. Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential. Curr Opin Drug Discov Devel. 2009;12(5):616\u201327.","journal-title":"Curr Opin Drug Discov Devel"},{"key":"1359_CR38","first-page":"461","volume":"7","author":"MF Konig","year":"2016","unstructured":"Konig MF, Andrade F. A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination. Front Immunol. 2016;7:461.","journal-title":"Front Immunol"},{"key":"1359_CR39","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, Jiang P, Guo S, Schrodi SJ, He D. Apoptosis, autophagy, NETosis, necroptosis, and pyroptosis mediated programmed cell death as targets for innovative therapy in rheumatoid arthritis. Front Immunol. 2021;12: 809806.","journal-title":"Front Immunol"},{"issue":"12","key":"1359_CR40","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2019-215698","volume":"78","author":"T Kissel","year":"2019","unstructured":"Kissel T, van Schie KA, Hafkenscheid L, Lundquist A, Kokkonen H, Wuhrer M, et al. On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis. Ann Rheum Dis. 2019;78(12):1616\u201320.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1359_CR41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/annrheumdis-2019-215337","volume":"78","author":"R Toes","year":"2019","unstructured":"Toes R, Pisetsky D. Pathogenic effector functions of ACPA: Where do we stand? Ann Rheum Dis. 2019;78(6):716\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1359_CR42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/annrheumdis-2015-208308","volume":"75","author":"J Sokolove","year":"2016","unstructured":"Sokolove J, Pisetsky D. Bone loss, pain and inflammation: three faces of ACPA in RA pathogenesis. Ann Rheum Dis. 2016;75(4):637\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1359_CR43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/imr.12829","volume":"294","author":"M Volkov","year":"2020","unstructured":"Volkov M, van Schie KA, van der Woude D. Autoantibodies and B Cells: the ABC of rheumatoid arthritis pathophysiology. Immunol Rev. 2020;294(1):148\u201363.","journal-title":"Immunol Rev"},{"issue":"1","key":"1359_CR44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand CM, Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol. 2021;22(1):10\u20138.","journal-title":"Nat Immunol"},{"key":"1359_CR45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/art.42320","volume":"75","author":"A Krishnamurthy","year":"2022","unstructured":"Krishnamurthy A, Circiumaru A, Sun J, Kisten Y, Damberg P, Sakuraba K, et al. Combination of two monoclonal anti-citrullinated protein antibodies induced tenosynovitis, pain, and bone loss in mice in a peptidyl arginine deiminase-4-dependent manner. Arthrit Rheumatol (Hoboken, NJ). 2022;75:164\u201370.","journal-title":"Arthrit Rheumatol (Hoboken, NJ)."},{"issue":"12","key":"1359_CR46","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1136\/annrheumdis-2015-208887","volume":"75","author":"C Clavel","year":"2016","unstructured":"Clavel C, Ceccato L, Anquetil F, Serre G, Sebbag M. Among human macrophages polarised to different phenotypes, the M-CSF-oriented cells present the highest pro-inflammatory response to the rheumatoid arthritis-specific immune complexes containing ACPA. Ann Rheum Dis. 2016;75(12):2184\u201391.","journal-title":"Ann Rheum Dis"},{"key":"1359_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108360","volume":"212","author":"SE Elliott","year":"2020","unstructured":"Elliott SE, Kongpachith S, Lingampalli N, Adamska JZ, Cannon BJ, Blum LK, et al. B cells in rheumatoid arthritis synovial tissues encode focused antibody repertoires that include antibodies that stimulate macrophage TNF-alpha production. Clin Immunol. 2020;212: 108360.","journal-title":"Clin Immunol"},{"issue":"3","key":"1359_CR48","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41423-019-0201-9","volume":"17","author":"X Dong","year":"2020","unstructured":"Dong X, Zheng Z, Lin P, Fu X, Li F, Jiang J, et al. ACPAs promote IL-1\u03b2 production in rheumatoid arthritis by activating the NLRP3 inflammasome. Cell Mol Immunol. 2020;17(3):261\u201371.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"1359_CR49","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1126\/sciimmunol.aal3062","volume":"2","author":"B Sun","year":"2017","unstructured":"Sun B, Dwivedi N, Bechtel T, Paulsen J, Muth A, Bawadekar M, et al. Citrullination of NF-\u03baB p65 promotes its nuclear localization and TLR-induced expression of IL-1\u03b2 and TNF\u03b1. Sci Immunol. 2017;2(12):3062.","journal-title":"Sci Immunol"},{"issue":"7","key":"1359_CR50","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","volume":"385","author":"G Schett","year":"2021","unstructured":"Schett G, Longo DL, McInnes IB, Neurath MF. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med. 2021;385(7):628\u201339.","journal-title":"N Engl J Med"},{"issue":"7","key":"1359_CR51","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12854","volume":"53","author":"X Yang","year":"2020","unstructured":"Yang X, Chang Y, Wei W. Emerging role of targeting macrophages in rheumatoid arthritis: focus on polarization, metabolism and apoptosis. Cell Prolif. 2020;53(7): e12854.","journal-title":"Cell Prolif"},{"issue":"3","key":"1359_CR52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molmed.2018.12.008","volume":"25","author":"LJ O'Neil","year":"2019","unstructured":"O\u2019Neil LJ, Kaplan MJ. Neutrophils in rheumatoid arthritis: breaking immune tolerance and fueling disease. Trends Mol Med. 2019;25(3):215\u201327.","journal-title":"Trends Mol Med"},{"issue":"9","key":"1359_CR53","first-page":"2250","volume":"105","author":"I De la Rosa","year":"2020","unstructured":"De la Rosa I, Perez-Sanchez C, Ruiz-Limon P, Pati\u00f1o-Trives A, Torres-Granados C, Jimenez-Gomez Y, et al. Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Mod Biol Ther Haematol. 2020;105(9):2250\u201361.","journal-title":"Mod Biol Ther Haematol"},{"issue":"5","key":"1359_CR54","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1172\/JCI84538","volume":"126","author":"OE S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen OE, Borregaard N. Neutrophil extracellular traps: the dark side of neutrophils. J Clin Investig. 2016;126(5):1612\u201320.","journal-title":"J Clin Investig"},{"key":"1359_CR55","doi-asserted-by":"crossref","first-page":"24437","DOI":"10.7554\/eLife.24437","volume":"6","author":"E Kenny","year":"2017","unstructured":"Kenny E, Herzig A, Kr\u00fcger R, Muth A, Mondal S, Thompson P, et al. Diverse stimuli engage different neutrophil extracellular trap pathways. Elife. 2017;6:24437.","journal-title":"Elife"},{"key":"1359_CR56","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.molimm.2019.05.012","volume":"112","author":"EA Bemis","year":"2019","unstructured":"Bemis EA, Norris JM, Seifert J, Frazer-Abel A, Okamoto Y, Feser ML, et al. Complement and its environmental determinants in the progression of human rheumatoid arthritis. Mol Immunol. 2019;112:256\u201365.","journal-title":"Mol Immunol"},{"key":"1359_CR57","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/art.42555","volume":"75","author":"R Scheinman","year":"2023","unstructured":"Scheinman R, Banda N. Does complement play a role in pathogenic ACPA? Arthrit Rheumatol (Hoboken, NJ). 2023;75:2062\u20133.","journal-title":"Arthrit Rheumatol (Hoboken, NJ)."},{"key":"1359_CR58","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3389\/fimmu.2019.01483","volume":"10","author":"U Steffen","year":"2019","unstructured":"Steffen U, Schett G, Bozec A. How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis. Front Immunol. 2019;10:1483.","journal-title":"Front Immunol"},{"issue":"11","key":"1359_CR59","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.1800534","volume":"202","author":"A Krishnamurthy","year":"2019","unstructured":"Krishnamurthy A, Ytterberg AJ, Sun M, Sakuraba K, Steen J, Joshua V, et al. Citrullination controls dendritic cell transdifferentiation into osteoclasts. J Immunol. 2019;202(11):3143\u201350.","journal-title":"J Immunol"},{"key":"1359_CR60","volume":"12","author":"J Qiu","year":"2021","unstructured":"Qiu J, Wu B, Goodman SB, Berry GJ, Goronzy JJ, Weyand CM. Metabolic control of autoimmunity and tissue inflammation in rheumatoid arthritis. Front Immunol. 2021;12: 652771.","journal-title":"Front Immunol"},{"issue":"1","key":"1359_CR61","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/annrheumdis-2013-203565","volume":"74","author":"Y Rombouts","year":"2015","unstructured":"Rombouts Y, Ewing E, van de Stadt LA, Selman MH, Trouw LA, Deelder AM, et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis. 2015;74(1):234\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1359_CR62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrrheum.2016.200","volume":"13","author":"AI Catrina","year":"2017","unstructured":"Catrina AI, Svensson CI, Malmstrom V, Schett G, Klareskog L. Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13(2):79\u201386.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"1359_CR63","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol. 2012;8(11):656\u201364.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1359_CR64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00281-017-0634-0","volume":"39","author":"U Harre","year":"2017","unstructured":"Harre U, Schett G. Cellular and molecular pathways of structural damage in rheumatoid arthritis. Semin Immunopathol. 2017;39(4):355\u201363.","journal-title":"Semin Immunopathol"},{"issue":"8","key":"1359_CR65","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41584-019-0244-4","volume":"15","author":"C Ge","year":"2019","unstructured":"Ge C, Holmdahl R. The structure, specificity and function of anti-citrullinated protein antibodies. Nat Rev Rheumatol. 2019;15(8):503\u20138.","journal-title":"Nat Rev Rheumatol"},{"key":"1359_CR66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.812962","volume":"13","author":"D Vasconcelos","year":"2022","unstructured":"Vasconcelos D, Jabangwe C, Lamghari M, Alves C. The neuroimmune interplay in joint pain: the role of macrophages. Front Immunol. 2022;13: 812962.","journal-title":"Front Immunol"},{"issue":"9","key":"1359_CR67","doi-asserted-by":"crossref","first-page":"104893","DOI":"10.1016\/j.isci.2022.104893","volume":"25","author":"I Arias-de la Rosa","year":"2022","unstructured":"Arias-de la Rosa I, Escudero-Contreras A, Ruiz-Ponce M, Cuesta-L\u00f3pez L, Rom\u00e1n-Rodr\u00edguez C, P\u00e9rez-S\u00e1nchez C, et al. Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis. iScience. 2022;25(9):104893.","journal-title":"iScience."},{"issue":"12","key":"1359_CR68","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1093\/rheumatology\/keac191","volume":"61","author":"JF Baker","year":"2022","unstructured":"Baker JF, England BR, George MD, Wysham K, Johnson T, Kunkel G, et al. Elevations in adipocytokines and mortality in rheumatoid arthritis. Rheumatology. 2022;61(12):4924\u201334.","journal-title":"Rheumatology"},{"key":"1359_CR69","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13075-015-0850-8","volume":"17","author":"E G\u00f3mez-Ba\u00f1uelos","year":"2015","unstructured":"G\u00f3mez-Ba\u00f1uelos E, Navarro-Hern\u00e1ndez R, Corona-Meraz F, Madrigal-Ru\u00edz P, Mart\u00edn-Marquez B, Pizano-Martinez O, et al. Serum leptin and serum leptin\/serum leptin receptor ratio imbalance in obese rheumatoid arthritis patients positive for anti-cyclic citrullinated peptide antibodies. Arthritis Res Ther. 2015;17:335.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1359_CR70","doi-asserted-by":"crossref","first-page":"e0144932","DOI":"10.1371\/journal.pone.0144459","volume":"10","author":"O Frey","year":"2015","unstructured":"Frey O, Maijer KI, Neumann E, M\u00fcller-Ladner U, Drop DACAD, Ramwadhdoebe TH, et al. Serum vaspin levels are associated with the development of clinically manifest arthritis in autoantibody-positive individuals. PLoS ONE. 2015;10(12):e0144932.","journal-title":"PLoS ONE"},{"issue":"3","key":"1359_CR71","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/acr.24790","volume":"75","author":"J Baker","year":"2023","unstructured":"Baker J, Katz P, Weber D, Gould P, George M, Long J, et al. Adipocytokines and associations with abnormal body composition in rheumatoid arthritis. Arthritis Care Res. 2023;75(3):616\u201324.","journal-title":"Arthritis Care Res"},{"issue":"9","key":"1359_CR72","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/ard.2011.150813","volume":"70","author":"J Giles","year":"2011","unstructured":"Giles J, van der Heijde D, Bathon J. Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis. Ann Rheum Dis. 2011;70(9):1562\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1359_CR73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12016-021-08890-1","volume":"63","author":"MV Sokolova","year":"2022","unstructured":"Sokolova MV, Schett G, Steffen U. Autoantibodies in rheumatoid arthritis: historical background and novel findings. Clin Rev Allergy Immunol. 2022;63(2):138\u201351.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"1359_CR74","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.41381","volume":"72","author":"H Westerlind","year":"2020","unstructured":"Westerlind H, R\u00f6nnelid J, Hansson M, Alfredsson L, Mathsson-Alm L, Serre G, et al. Anti-citrullinated protein antibody specificities, rheumatoid factor isotypes, and incident cardiovascular events in patients with rheumatoid arthritis. Arthritis & Rheumatol (Hoboken, NJ). 2020;72(10):1658\u201367.","journal-title":"Arthritis & Rheumatol (Hoboken, NJ)"},{"issue":"8","key":"1359_CR75","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/acr.23106","volume":"69","author":"L Geraldino-Pardilla","year":"2017","unstructured":"Geraldino-Pardilla L, Giles JT, Sokolove J, Zartoshti A, Robinson WH, Budoff M, et al. Association of anti-citrullinated peptide antibodies with coronary artery calcification in rheumatoid arthritis. Arthritis Care Res. 2017;69(8):1276\u201381.","journal-title":"Arthritis Care Res"},{"issue":"3","key":"1359_CR76","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s13679-020-00397-8","volume":"9","author":"C Tsigalou","year":"2020","unstructured":"Tsigalou C, Vallianou N, Dalamaga M. Autoantibody production in obesity: Is there evidence for a link between obesity and autoimmunity? Curr Obes Rep. 2020;9(3):245\u201354.","journal-title":"Curr Obes Rep"},{"key":"1359_CR77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2023.08.002","volume":"118","author":"I Arias-de la Rosa","year":"2023","unstructured":"Arias-de la Rosa I, Ruiz-Ponce M, Cuesta-L\u00f3pez L, P\u00e9rez-S\u00e1nchez C, Leiva-Cepas F, Gahete M, et al. Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis. Eur J Internal Med. 2023;118:49\u201358.","journal-title":"Eur J Internal Med"},{"issue":"10086","key":"1359_CR78","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389(10086):2328\u201337.","journal-title":"Lancet"},{"issue":"1","key":"1359_CR79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42358-018-0042-8","volume":"59","author":"RS de Brito","year":"2019","unstructured":"de Brito RS, Baldo DC, Andrade LEC. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis. Adv Rheumatol. 2019;59(1):2.","journal-title":"Adv Rheumatol"},{"key":"1359_CR80","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, Guo S, Schrodi S, He D. Molecular and cellular heterogeneity in rheumatoid arthritis: mechanisms and clinical implications. Front Immunol. 2021;12: 790122.","journal-title":"Front Immunol"},{"key":"1359_CR81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115040","volume":"200","author":"I Thirugnanasambandham","year":"2022","unstructured":"Thirugnanasambandham I, Radhakrishnan A, Kuppusamy G, Kumar Singh S, Dua K. Peptidylarginine deiminase-4: Medico-formulative strategy towards management of rheumatoid arthritis. Biochem Pharmacol. 2022;200: 115040.","journal-title":"Biochem Pharmacol"},{"key":"1359_CR82","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716250","volume":"12","author":"MT Martin Monreal","year":"2021","unstructured":"Martin Monreal MT, Rebak AS, Massarenti L, Mondal S, Senolt L, Odum N, et al. Applicability of small-molecule inhibitors in the study of peptidyl arginine deiminase 2 (PAD2) and PAD4. Front Immunol. 2021;12: 716250.","journal-title":"Front Immunol"},{"issue":"2","key":"1359_CR83","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/cei.12932","volume":"188","author":"VC Willis","year":"2017","unstructured":"Willis VC, Banda NK, Cordova KN, Chandra PE, Robinson WH, Cooper DC, et al. Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis. Clin Exp Immunol. 2017;188(2):263\u201374.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1359_CR84","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41423-019-0201-9","volume":"17","author":"X Dong","year":"2020","unstructured":"Dong X, Zheng Z, Lin P, Fu X, Li F, Jiang J, et al. ACPAs promote IL-1beta production in rheumatoid arthritis by activating the NLRP3 inflammasome. Cell Mol Immunol. 2020;17(3):261\u201371.","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"1359_CR85","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/eji.201646542","volume":"46","author":"G Papadaki","year":"2016","unstructured":"Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, et al. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur J Immunol. 2016;46(11):2542\u201354.","journal-title":"Eur J Immunol"},{"issue":"1","key":"1359_CR86","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ddr.21608","volume":"81","author":"VM Vargas-Mu\u00f1oz","year":"2020","unstructured":"Vargas-Mu\u00f1oz VM, Mart\u00ednez-Mart\u00ednez A, Mu\u00f1oz-Islas E, Ram\u00edrez-Rosas MB, Acosta-Gonz\u00e1lez RI, Jim\u00e9nez-Andrade JM. Chronic administration of Cl-amidine, a pan-peptidylarginine deiminase inhibitor, does not reverse bone loss in two different murine models of osteoporosis. Drug Dev Res. 2020;81(1):93\u2013101.","journal-title":"Drug Dev Res"},{"issue":"12","key":"1359_CR87","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1136\/annrheumdis-2014-205365","volume":"74","author":"JS Knight","year":"2015","unstructured":"Knight JS, Subramanian V, O\u2019Dell AA, Yalavarthi S, Zhao W, Smith CK, et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL\/lpr mice. Ann Rheum Dis. 2015;74(12):2199\u2013206.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1359_CR88","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nchembio.1735","volume":"11","author":"HD Lewis","year":"2015","unstructured":"Lewis HD, Liddle J, Coote JE, Atkinson SJ, Barker MD, Bax BD, et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol. 2015;11(3):189\u201391.","journal-title":"Nat Chem Biol"},{"issue":"19","key":"1359_CR89","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1158\/0008-5472.CAN-21-4045","volume":"82","author":"H Deng","year":"2022","unstructured":"Deng H, Lin C, Garcia-Gerique L, Fu S, Cruz Z, Bonner EE, et al. A novel selective inhibitor JBI-589 targets PAD4-mediated neutrophil migration to suppress tumor progression. Cancer Res. 2022;82(19):3561\u201372.","journal-title":"Cancer Res"},{"key":"1359_CR90","doi-asserted-by":"crossref","unstructured":"Corrigendum to \"The PAD4 inhibitor GSK484 enhances the radiosensitivity of triple-negative breast cancer\". Hum Exp Toxicol. 2021;40(11):2022.","DOI":"10.1177\/09603271211054329"},{"issue":"2","key":"1359_CR91","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","volume":"61","author":"V Mutua","year":"2021","unstructured":"Mutua V, Gershwin LJ. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clin Rev Allergy Immunol. 2021;61(2):194\u2013211.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"1359_CR92","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/s41423-020-0381-3","volume":"18","author":"RGS Chirivi","year":"2021","unstructured":"Chirivi RGS, van Rosmalen JWG, van der Linden M, Euler M, Schmets G, Bogatkevich G, et al. Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases. Cell Mol Immunol. 2021;18(6):1528\u201344.","journal-title":"Cell Mol Immunol"},{"key":"1359_CR93","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3389\/fimmu.2019.02462","volume":"10","author":"A Hawez","year":"2019","unstructured":"Hawez A, Al-Haidari A, Madhi R, Rahman M, Thorlacius H. MiR-155 regulates PAD4-dependent formation of neutrophil extracellular traps. Front Immunol. 2019;10:2462.","journal-title":"Front Immunol"},{"issue":"11","key":"1359_CR94","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.autrev.2018.06.006","volume":"17","author":"I Cecchi","year":"2018","unstructured":"Cecchi I, AriasdelaRosa I, Menegatti E, Roccatello D, Collantes-Estevez E, Lopez-Pedrera C, et al. Neutrophils: Novel key players in Rheumatoid Arthritis: current and future therapeutic targets. Autoimmun Rev. 2018;17(11):1138\u201349.","journal-title":"Autoimmun Rev"},{"key":"1359_CR95","doi-asserted-by":"crossref","first-page":"750753","DOI":"10.3389\/fimmu.2021.750753","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J, et al. B Cells in rheumatoid arthritis: pathogenic mechanisms and treatment prospects. Front Immunol. 2021;12:750753.","journal-title":"Front Immunol"},{"key":"1359_CR96","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaut.2019.04.016","volume":"101","author":"R Lorenzetti","year":"2019","unstructured":"Lorenzetti R, Janowska I, Smulski C, Frede N, Henneberger N, Walter L, et al. Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. J Autoimmun. 2019;101:145\u201352.","journal-title":"J Autoimmun"},{"issue":"2","key":"1359_CR97","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/annrheumdis-2020-217844","volume":"80","author":"B Zhang","year":"2021","unstructured":"Zhang B, Wang Y, Yuan Y, Sun J, Liu L, Huang D, et al. In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells. Ann Rheum Dis. 2021;80(2):176\u201384.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1359_CR98","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/14397595.2019.1583784","volume":"30","author":"A Noguchi","year":"2020","unstructured":"Noguchi A, Yasuda S, Hisada R, Kato M, Oku K, Bohgaki T, et al. Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: a pilot study. Mod Rheumatol. 2020;30(2):276\u201381.","journal-title":"Mod Rheumatol"},{"issue":"10041","key":"1359_CR99","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(16)00380-9","volume":"388","author":"D Porter","year":"2016","unstructured":"Porter D, van Melckebeke J, Dale J, Messow C, McConnachie A, Walker A, et al. Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial. Lancet (London, England). 2016;388(10041):239\u201347.","journal-title":"Lancet (London, England)"},{"key":"1359_CR100","first-page":"1","volume":"2018","author":"W Chen","year":"2018","unstructured":"Chen W, Wang Q, Ke Y, Lin J. Neutrophil function in an inflammatory milieu of rheumatoid arthritis. J Immunol Res. 2018;2018:1\u201312.","journal-title":"J Immunol Res"},{"issue":"23","key":"1359_CR101","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1021\/bi100363t","volume":"49","author":"B Knuckley","year":"2010","unstructured":"Knuckley B, Causey CP, Jones JE, Bhatia M, Dreyton CJ, Osborne TC, et al. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. Biochemistry. 2010;49(23):4852\u201363.","journal-title":"Biochemistry"},{"issue":"5","key":"1359_CR102","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s11596-022-2637-x","volume":"42","author":"Y Sun","year":"2022","unstructured":"Sun Y, Ma Y, Jia X, Yao Q, Chen J, Li H. Inducement of ER stress by PAD inhibitor BB-Cl-amidine to effectively kill AML cells. Curr Med Sci. 2022;42(5):958\u201365.","journal-title":"Curr Med Sci"},{"issue":"1","key":"1359_CR103","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000448808","volume":"9","author":"B Biron","year":"2017","unstructured":"Biron B, Chung C, O\u2019Brien X, Chen Y, Reichner J, Ayala A. Cl-amidine prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model. J Innate Immun. 2017;9(1):22\u201332.","journal-title":"J Innate Immun"},{"key":"1359_CR104","volume":"161","author":"Y He","year":"2020","unstructured":"He Y, Huang Y, Mai C, Pan H, Luo HB, Liu L, et al. The immunomodulatory role of PDEs inhibitors in immune cells: therapeutic implication in rheumatoid arthritis. Pharmacol Res. 2020;161: 105134.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1359_CR105","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1038\/s41598-023-30246-2","volume":"13","author":"C Gajendran","year":"2023","unstructured":"Gajendran C, Fukui S, Sadhu NM, Zainuddin M, Rajagopal S, Gosu R, et al. Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4. Sci Rep. 2023;13(1):3189.","journal-title":"Sci Rep"},{"issue":"1","key":"1359_CR106","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.42665","volume":"76","author":"A Paoletti","year":"2024","unstructured":"Paoletti A, Ly B, Cailleau C, Gao F, de Ponfilly-Sotier M, Pascaud J, et al. Liposomal ANTAGOMIR-155-5p restores anti-inflammatory macrophages and improves arthritis in preclinical models of rheumatoid arthritis. Arthritis Rheumatol (Hoboken, NJ). 2024;76(1):18\u201331.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"1359_CR107","first-page":"79","volume":"58","author":"Z Jun","year":"2023","unstructured":"Jun Z, Yan L, Xiaoyi S, Junlong D, Yu L, Siwen L, et al. Infusion of GMSCs relieves autoimmune arthritis by suppressing the externalization of neutrophil extracellular traps via PGE2-PKA-ERK axis. J Adv Res. 2023;58:79\u201391.","journal-title":"J Adv Res"},{"key":"1359_CR108","first-page":"87","volume":"183","author":"P Ruiz-Lim\u00f3n","year":"2017","unstructured":"Ruiz-Lim\u00f3n P, Ortega R, Arias de la Rosa I, Abalos-Aguilera M, Perez-Sanchez C, Jimenez-Gomez Y, et al. Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation. Transl Res J Lab Clin Med. 2017;183:87\u2013103.","journal-title":"Transl Res J Lab Clin Med"},{"issue":"1","key":"1359_CR109","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13075-018-1527-x","volume":"20","author":"A Bozec","year":"2018","unstructured":"Bozec A, Luo Y, Engdahl C, Figueiredo C, Bang H, Schett G. Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner. Arthritis Res Ther. 2018;20(1):24.","journal-title":"Arthritis Res Ther"},{"key":"1359_CR110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-065X.2008.00627.x","volume":"223","author":"G Silverman","year":"2008","unstructured":"Silverman G, Boyle D. Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesis. Immunol Rev. 2008;223:175\u201385.","journal-title":"Immunol Rev"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-024-01359-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01359-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:24:02Z","timestamp":1732987442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-024-01359-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1007\/s10238-024-01359-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"23 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests, or other interests that might be perceived to influence the results and\/or discussion reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors concur with the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"153"}}